Verda Bio

📍 Seattle, United States🗓 Founded 2013👥 3 employees💰 Last funded Jun 2018
Verda Bio seeks to bring scientific expertise to product formulation and dosing of cannabinoid based therapeutics (CBTs). At Verda Bio, we are performing research on CBTs using the latest scientific technology to perform genomic, analytical, and clinical research on CBTs. At Verda Bio, genomic and analytical data will serve as the backbone for CBT development. By combining analytical chemistry, technology, and genomic data, Verda Bio will be able to control for the variability in many cannabis strains and create CBTs (cannabinoid based therapeutics) that selectively and consistently meet the needs of specific patient populations.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2013
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Verda Bio?
Verda Bio has 1 investors on record on gritt.io, 1 mid-stage.
When did Verda Bio last raise funding?
The most recent investment in Verda Bio recorded on gritt.io was in June 2018.
When was Verda Bio founded?
Verda Bio was founded in 2013.
What industry is Verda Bio in?
Verda Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Verda Bio based?
Verda Bio is headquartered in Seattle, United States.